Devices

Device Recall Micromax Anchors,

  • Modèle / numéro de série
    40370, 40380, 193300, 193390, 193420, 262880, 262890, 262900, 295530, 295540, 314440, 377910, 377930, 430410, 430420, 430430, 430440, 435400, 435410, 435420, 463950, 463960, 464240, 499820, 610320, 610330, 610340, 727730, 727740, 727760, 727770, 727800, 727810, 727830, 83271040370, 40380, 193300, 193390, 193420, 262880, 262890, 262900, 295530, 295540, 314440, 377910, 37793040370, 40380, 193300, 193390, 193420, 262880, 262890, 262900, 295530, 295540, 314440, 377910, 377930, 430410, 430420, 430430, 430440, 435400, 435410, 435420, 463950, 463960, 464240, 499820, 610320, 610330, 610340, 727730, 727740, 727760, 727770, 727800, 727810, 727830, 832710, 430410, 430420, 430430, 430440, 435400, 435410, 435420, 463950, 463960, 464240, 499820, 610320, 610330, 610340, 727730, 727740, 727760, 727770, 727800, 727810, 727830, 832710.
  • Classification du dispositif
    Orthopedic Devices
  • Classe de dispositif
    2
  • Dispositif implanté ?
    Yes
  • Distribution
    Worldwide Distribution - USA (nationwide) and the countries of: Argentina, Brazil, Chile, Colombia, Israel, Mexico and Netherlands.
  • Description du dispositif
    REF 905570 3.5 mm Lactoscrew Anchor Size 2 white Maxbraid ,(Lactosorb L-15 resorbable copolymer ) Sterile, EO; Biomet Sports Medicine, Warsaw, IN || Product Usage: The Biomet Sports Medicine Soft Tissue Anchoring Devices are resorbable repair devices used to attach soft tissue to bone.
  • Manufacturer
    Biomet, Inc.
  • 1 Event

Fabricant

Biomet, Inc.
  • Adresse du fabricant
    Biomet, Inc., 56 E Bell Dr, Warsaw IN 46582-6989
  • Société-mère du fabricant (2017)
    Zimmer Biomet Holdings
  • Commentaire du fabricant
    “The safety of patients has always been, and continues to be, Zimmer Biomet’s top priority and it is our honor to be a leader in this industry for the past 90 years,” Zimmer Biomet told ICIJ in a statement. “We adhere to strict regulatory standards, and work closely with the FDA and all applicable regulatory agencies in each of our regions as part of our commitment to operating a first-rate quality management system across our global manufacturing network. The company added that it is focused on staying at the forefront of innovation and doing right by the millions of patients who rely on the company’s products.
  • Source
    USFDA